2022-02-25 03:01 ET - News Release
Toronto, Ontario--(Newsfile Corp. - February 25, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company has been awarded seven (7) new Covid testing contracts from major, well-known film production companies in Vancouver and Toronto, and now has over 45% of the market share for Covid testing in the film production industry in Vancouver.
"We are excited that the Company continues to gain a strong reputation in the film production industry and continue to be awarded contracts. We continue to forecast a strong 2022 with revenues from Covid testing and expansion into new offerings," said Lena Kozovski, CEO of the Company.
About ScreenPro
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO
Email: info@screenprosecurity.com